5-Geranyloxy-7-methoxycoumarin inhibits colon cancer (SW480) cells growth by inducing apoptosis

Planta Medica

Volumn 79, Issue 3-4, 2013, Pages 219-226

  Patil, Jaiprakash R ^a,b   Jayaprakasha, Guddadarangavvanahally K ^a   Kim, Jinhee ^a   Murthy, Kotamballi N Chidambara ^a   Chetti, Mahadev B ^b   Nam, Sang Yong ^c   Patil, Bhimanagouda S ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF AGRICULTURAL SCIENCES   (India)

^c Sahmyook University   (South Korea)

Author keywords

5 geranyloxy 7 methoxycoumarin; apoptosis; Citrus aurantifolia L. Osbeck; colon cancer; coumarins; Rutaceae

Indexed keywords

5 GERANYLOXY 7 METHOXYCOUMARIN; 5,7 DIMETHOXYCOUMARIN; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; COUMARIN DERIVATIVE; ISOPIMPINELLIN; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARBON NUCLEAR MAGNETIC RESONANCE; CELL PROLIFERATION; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; G1 PHASE CELL CYCLE CHECKPOINT; HETERONUCLEAR MULTIPLE QUANTUM COHERENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PROTEIN PHOSPHORYLATION; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CITRUS AURANTIIFOLIA; COLONIC NEOPLASMS; COUMARINS; DNA FRAGMENTATION; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; PSORALENS; TUMOR SUPPRESSOR PROTEIN P53;

CITRUS AURANTIIFOLIA; RUTACEAE;

EID: 84874931788     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1328130     Document Type: Article

References (56)

1. Gray A. I., Waterman P. G. Coumarins in the Rutaceae. Phytochemistry: 1978; 17 845 864
2. McHale D., Sheridan J. B. The oxygen heterocyclic compounds of citrus peel oils. J Essent Oil Res: 1989; 1 139 149
3. Tatum J. H., Berry R. E. 6,7-Dimethoxycoumatin in the peels of Citrus. Phytochemistry: 1977; 16 1091 1092
4. Gray A. I., Waterman P. G. Coumarins in the Rutaceae. Phytochemistry: 1978; 17 845 864
5. Murakami A. W., Kuki W., Takahashi Y., Yonei H., Nakamura Y., Ohto Y., Ohigashi H., Koshimizu K. Auraptene, a citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin possibly through suppression of superoxide generation in leukocytes. Jpn J Cancer Res: 1997; 88 443 452 (Pubitemid 27267606)
6. Paya M., Ferrandiz M. L., Miralles F., Montesinos C., Ubeda A., Alcaraz M. J. Effects of coumarin derivatives on superoxide anion generation. Arzneimittelforschung: 1993; 43 655 658 (Pubitemid 23176489)
7. Girennavar B., Jayaprakasha G. K., Jadegoud Y., Nagana Gowda G. A., Patil B. S. Radical scavenging and cytochrome P450 3A4 inhibitory activity of bergaptol and geranylcoumarin from grapefruit. Bioorg Med Chem: 2007; 15 3684 3691 (Pubitemid 46656345)
8. Girennavar B., Poulose S. M., Jayaprakasha G. K., Bhat N. G., Patil B. S. Furocoumarins from grapefruit juice and their effect on human CYP 3A4 and CYP 1B1 isoenzymes. Bioorg Med Chem: 2006; 14 2606 2612 (Pubitemid 43343648)
9. Wangensteen H., Molden E., Christensen H., Malterud K. E. Identification of epoxybergamottin as a CYP3A4 inhibitor in grapefruit peel. Eur J Clin Pharmacol: 2003; 58 663 668 (Pubitemid 36363294)
10. Patil B. S., Jayaprakasha G. K., Murthy K. NC, Seeram N. P. Emerging trends in dietary components for preventing and combating disease. Washington, DC Oxford University Press, Inc, ACS Symposium Series 1093, American Chemical Society: 2012
11. Jinhee K., Jayaprakasha G. K., Amit V., Bhimanagouda S. P. Cancer chemopreventive properties of Citrus limonoids. Emerging trends in dietary components for preventing and combating disease. Washington American Chemical Society: 2012; 37 50
12. Kotamballi N. CM, Jayaprakasha G. K., Shivappa M. M., Bhimanagouda S. P. Citrus monoterpenes: Potential source of phytochemicals for cancer prevention. Emerging trends in dietary components for preventing and combating disease. Washington American Chemical Society: 2012; 545 558
13. Kim M. J., Hae J. P., Mee S. H., Park H. J., Kim M. S., Leem K. H., Kim J. B., Youn J. K., Hye K. K. Citrus reticulata blanco induces apoptosis in human gastric cancer cells SNU-668. Nutr Cancer: 2005; 51 78 82 (Pubitemid 40365985)
14. Vanamala J., Leonardi T., Patil B. S., Taddeo S. S., Murphy M. E., Pike L. M., Chapkin R. S., Lupton J. R., Turner N. D. Suppression of colon carcinogenesis by bioactive compounds in grapefruit. Carcinogenesis: 2006; 27 1257 1265 (Pubitemid 43994864)
15. Jayaprakasha G. K., Mandadi K. K., Poulose S. M., Jadegoud Y., Nagana Gowda G. A., Patil B. S. Novel triterpenoid from Citrus aurantium L. possesses chemopreventive properties against human colon cancer cells. Bioorg Med Chem: 2008; 16 5939 5951 (Pubitemid 351758846)
16. Kim J., Jayaprakasha G. K., Muthuchamy M., Patil B. S. Structure-function relationships of citrus limonoids on p 38 MAP kinase activity in human aortic smooth muscle cells. Eur J Pharmacol: 2011; 670 44 49
17. Kim J., Jayaprakasha G. K., Uckoo R. M., Patil B. S. Evaluation of chemopreventive and cytotoxic effect of lemon seed extracts on human breast cancer (MCF-7) cells. Food Chem Toxicol: 2012; 50 423 430
18. Poulose S. M., Harris E. D., Patil B. S. Citrus limonoids induce apoptosis in human neuroblastoma cells and have radical scavenging activity. J Nutr: 2005; 135 870 877 (Pubitemid 40464118)
19. Patil J., Jayaprakasha G., Murthy K., Chetti M., Patil B. Characterization of Citrus aurantifolia bioactive compounds and their inhibition of human pancreatic cancer cells through apoptosis. Microchem J: 2010; 94 108 117
20. Jayaprakasha G. K., Murthy K. NC, Demarais R., Patil B. S. Inhibition of prostate cancer (LNCaP) cell proliferation by volatile components from Nagami kumquats. Planta Med: 2012; 78 974 980
21. Poulose S. M., Harris E. D., Patil B. S. Antiproliferative effects of citrus limonoids against human neuroblastoma and colonic adenocarcinoma cells. Nutr Cancer: 2006; 56 103 112 (Pubitemid 46173420)
22. Poulose M., Jayaprakasha G. K., Mayer R. T., Girennavar B., Patil B. S. Purification of citrus limonoids and their differential inhibitory effects on human cytochrome P450 enzymes. J Sci Food Agric: 2007; 87 1699 1709 (Pubitemid 46983824)
23. Patil J. R., Jayaprakasha G. K., Chidambara Murthy K. N., Tichy S. E., Chetti M. B., Patil B. S. Apoptosis-mediated proliferation inhibition of human colon cancer cells by volatile principles of Citrus aurantifolia. Food Chem: 2009; 114 1351 1358
24. Nabekura T., Yamaki T., Kitagawa S. Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1. Eur J Pharmacol: 2008; 600 45 49
25. Hirata T., Fujii M., Akita K., Yanaka N., Ogawa K., Kuroyanagi M., Hongo D. Identification and physiological evaluation of the components from citrus fruits as potential drugs for anti-corpulence and anticancer. Bioorg Med Chem: 2009; 17 25 28
26. Murat Bilgin H. I., Atmaca M., Deniz Obay B., Özekinci S., Tasdemir E., Ketani A. Protective effects of coumarin and coumarin derivatives against carbon tetrachloride-induced acute hepatotoxicity in rats. Exp Toxicol Pathol: 2011; 63 325 330
27. Patil J. B., Kim J., Jayaprakasha G. K. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. Eur J Pharmacol: 2010; 645 70 78
28. Taylor R. C., Cullen S. P., Martin S. J. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol: 2008; 9 231 241 (Pubitemid 351301823)
29. Desmortreux C., Rothaupt M., West C., Lesellier E. Improved separation of furocoumarins of essential oils by supercritical fluid chromatography. J Chromatogr A: 2009; 1216 7088 7095
30. Yang W., Feng C., Kong D., Shi X., Zheng X., Cui Y., Liu M., Zhang L., Wang Q. Simultaneous determination of 15 components in Radix Glehniae by high performance liquid chromatography-electrospray ionization tandem mass spectrometry. Food Chem: 2010; 120 886 894
31. Kang S., Seeram N., Nair M., Bourquin L. Tart cherry anthocyanins inhibit tumor development in ApcMin mice and reduce proliferation of human colon cancer cells. Cancer Lett: 2003; 194 13 19 (Pubitemid 36428880)
32. Kawamori T., Lubet R., Steele V. E., Kelloff G. J., Kaskey R. B., Rao C. V., Reddy B. S. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res: 1999; 59 597 601 (Pubitemid 29076056)
33. Borges F., Roleira F., Milhazes N., Santana L., Uriarte E. Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr Med Chem: 2005; 12 887 916 (Pubitemid 40443846)
34. Elinos-Báez C. M., León F., Santos E. Effects of coumarin and 7OH-coumarin on bcl-2 and Bax expression in two human lung cancer cell lines in vitro. Cell Biol Int: 2005; 29 703 708 (Pubitemid 41350753)
35. Bhattacharyya S. S., Paul S., Mandal S. K., Banerjee A., Boujedaini N., Khuda-Bukhsh A. R. A synthetic coumarin (4-methyl-7 hydroxy coumarin) has anti-cancer potentials against DMBA-induced skin cancer in mice. Eur J Pharmacol: 2009; 614 128 136
36. Thati B., Noble A., Creaven B. S., Walsh M., Kavanagh K., Egan D. A. An in vitro investigation of the induction of apoptosis and modulation of cell cycle events in human cancer cells by bisphenanthroline-coumarin-6,7- dioxacetatocopper(II) complex. Chem Biol Interact: 2007; 168 143 158 (Pubitemid 46901068)
37. Reddy N. S., Gumireddy K., Mallireddigari M. R., Cosenza S. C., Venkatapuram P., Bell S. C., Reddy E. P., Reddy M. VR. Novel coumarin-3-(N-aryl)carboxamides arrest breast cancer cell growth by inhibiting ErbB-2 and ERK1. Bioorg Med Chem: 2005; 13 3141 3147 (Pubitemid 40462117)
38. Nakajima M., Yoshida R., Shimada N., Yamazaki H., Yokoi T. Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate. Drug Metab Dispos: 2001; 29 1110 1113 (Pubitemid 32660529)
39. Vermes I., Haanen C., Steffens-Nakken H., Reutellingsperger C. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods: 1995; 184 39 51
40. Bortner C., Oldenburg N., Cidlowski J. The role of DNA fragmentation in apoptosis. Trends Cell Biol: 1995; 5 21 26
41. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell: 1997; 89 175 184 (Pubitemid 27199890)
42. Riedl S. J., Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Molecul Cell Biol: 2004; 5 897 907 (Pubitemid 39486541)
43. Chuang J. Y., Huang Y. F., Lu H. S., Ho H. C., Yang J. S., Li T. M., Chang N. W., Chung J. G. Coumarin induces cell cycle arrest and apoptosis in human cervical cancer HeLa cells through a mitochondria-and caspase-3 dependent mechanism and NF-κB down-regulation. In Vivo: 2007; 21 1003 1009
44. Lopez-Gonzalez J. S., Prado-Garcia H., Aguilar-Cazares D., Molina-Guarneros J. A., Morales-Fuentes J., Mandoki J. J. Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines. Lung Cancer: 2004; 43 275 283 (Pubitemid 38224147)
45. Selivanova G. p 53: fighting cancer. Curr Cancer Drug Targets: 2004; 4 385 402
46. Wang D., Lippard S. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov: 2005; 4 307 320 (Pubitemid 41130944)
47. Vassilev L. p 53 Activation by small molecules: application in oncology. J Med Chem: 2005; 48 4491 4499 (Pubitemid 40993409)
48. Wu G. S. The functional interactions between the p 53 and MAPK signaling pathways. Cancer Biol Ther: 2004; 3 156 161
49. Adams J. M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science: 1998; 281 1322 1326 (Pubitemid 28406819)
50. Joensuu H., Pylkkänen L., Toikkanen S. Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol: 1994; 145 1191 1198 (Pubitemid 24345666)
51. Sheng H., Shao J., Morrow J. D., Beauchamp R. D., DuBois R. N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res: 1998; 58 362 366 (Pubitemid 28047080)
52. Sinicrope F. A., Ruan S. B., Cleary K. R., Stephens L. C., Lee J. J., Levin B. bcl-2 and p 53 oncoprotein expression during colorectal tumorigenesis. Cancer Res: 1995; 55 237 241
53. Fontanini G., Vignati S., Bigini D., Mussi A., Lucchi M., Angeletti C., Basolo F., Bevilacqua G. Bcl-2 protein: a prognostic factor inversely correlated to p 53 in non-small-cell lung cancer. Br J Cancer: 1995; 71 1003 1007
54. Genovese S., Curini M., Gresele P., Corazzi T., Epifano F. Inhibition of COX-1 activity and COX-2 expression by 3-(4′-geranyloxy-3′- methoxyphenyl)-2-trans propenoic acid and its semi-synthetic derivatives. Bioorg Med Chem Lett: 2011; 21 5995 5998
55. Hori K., Sakaguchi A., Kudoh M., Ishida K., Aoyama Y., Yoshida Y. Structure-activity relationships of a new antifungal imidazole, AFK-108, and related compounds. Chem Pharm Bull Tokyo: 2000; 48 60 64 (Pubitemid 30074941)
56. Kawase M., Sakagami H., Hashimoto K., Tani S., Hauer H., Chatterjee S. S. Structure-cytotoxic activity relationships of simple hydroxylated coumarins. Anticancer Res: 2003; 23 3243 3246 (Pubitemid 36975419)